Tuberculosis (TB) Treatment Regimen Calculator
Use this clinical calculator to determine the precise weight-based dosing regimens for standard first-line anti-tuberculosis (TB) therapy. Adhering to exact weight-based therapeutic windows is critical to ensuring rapid bacterial clearance, minimizing the risk of drug resistance, and reducing hepatotoxic and ocular side effects. This tool processes patient weight to deliver optimized dosing for the intensive phase of treatment using the standard HRZE regimen (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol) in accordance with global public health and clinical guidelines.
Disclaimer: This calculator is for educational purposes for healthcare professionals. Always adhere to your local National Tuberculosis Control Program (NTP) guidelines and clinical judgment.
Understanding First-Line Anti-TB Dosing (HRZE Regimen)
The pharmacological management of active, drug-susceptible Mycobacterium tuberculosis relies on a combination of four primary medications during the initial 2-month intensive phase. Precise weight-based dosing is vital, as under-dosing leads to treatment failure and acquired drug resistance, while over-dosing significantly increases the risk of severe drug-induced liver injury (DILI).
The standard first-line regimen consists of:
Isoniazid (H): A potent bactericidal agent targeting mycolic acid synthesis.
Rifampicin (R): Inhibits bacterial RNA synthesis, crucial for clearing both active and semi-dormant bacilli.
Pyrazinamide (Z): Sterilizes the acidic intracellular environment within macrophages; the maximum daily dose is strictly capped at 2000 mg to prevent severe hepatotoxicity.
Ethambutol (E): A bacteriostatic drug that disrupts cell wall synthesis, protecting against resistance if hidden baseline resistance to isoniazid exists.
Standard Weight-Based Dosing Parameters
For adult regimens, the calculation follows standardized milligram-per-kilogram (mg/kg) guidelines, with absolute maximum daily caps applied regardless of weight:
Isoniazid (H): Standard daily dose is 5 mg/kg (range: 4 - 6 mg/kg). Maximum daily cap is 300 mg.
Rifampicin (R): Standard daily dose is 10 mg/kg (range: 8 - 12 mg/kg). Maximum daily cap is 600 mg.
Pyrazinamide (Z): Standard daily dose is 25 mg/kg (range: 20 - 30 mg/kg). Maximum daily cap is 2000 mg.
Ethambutol (E): Standard daily dose is 15 mg/kg (range: 15 - 25 mg/kg). Maximum daily cap is 1600 mg.
Clinical Considerations and Monitoring
When prescribing anti-tuberculosis therapy, clinicians must implement baseline assessments and ongoing clinical monitoring to guarantee patient safety:
Hepatic Monitoring: Baseline liver function tests (LFTs), including ALT, AST, and bilirubin, should be checked. Isoniazid, Rifampicin, and Pyrazinamide are all potentially hepatotoxic.
Ocular Toxicity: Ethambutol can cause dose-dependent optic neuritis. Patients should undergo baseline visual acuity and red-green color distinction testing before starting the medication.
Pyridoxine Supplementation: To prevent peripheral neuropathy induced by Isoniazid, daily supplementation of Vitamin B6 (Pyridoxine, 10 - 25 mg/day) should be co-prescribed, particularly in pregnant women, malnourished individuals, or patients with chronic alcohol dependence or diabetes.
Got any Suggestion?
Contact:
info@histamind.com